Persani Luca, Bonomi Marco
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Division of Endocrine and Metabolic Diseases, San Luca Hospital, Istituto Auxologico Italiano, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Division of Endocrine and Metabolic Diseases, San Luca Hospital, Istituto Auxologico Italiano, Milan, Italy.
Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):255-263. doi: 10.1016/j.beem.2017.04.003. Epub 2017 Apr 17.
An insufficient stimulation by thyrotropin (TSH) of an otherwise normal thyroid gland represents the cause of Central Hypothyrodism (CeH). CeH is about 1000-folds rarer than Primary Hypothyroidism and often represents a real challenge for the clinicians, mainly because they cannot rely on adequately sensitive parameters for diagnosis or management, as it occurs with circulating TSH in PH. Therefore, CeH diagnosis can be frequently missed or delayed in patients with a previously unknown pituitary involvement. A series of genetic defects have been described to account for isolated CeH or combined pituitary hormone defects (CPHDs) with variable clinical characteristics and degrees of severity. The recently identified candidate gene IGSF1 appears frequently involved. This review provides an updated illustration of the different genetic defects accounting for CeH.
促甲状腺激素(TSH)对原本正常的甲状腺刺激不足是中枢性甲状腺功能减退症(CeH)的病因。CeH比原发性甲状腺功能减退症罕见约1000倍,对临床医生来说常常是一个真正的挑战,主要是因为他们无法像原发性甲状腺功能减退症(PH)中依赖循环TSH那样,依靠足够敏感的参数进行诊断或管理。因此,对于先前未知垂体受累的患者,CeH的诊断常常会被漏诊或延误。一系列遗传缺陷已被描述可导致孤立性CeH或伴有不同临床特征和严重程度的联合垂体激素缺陷(CPHDs)。最近发现的候选基因IGSF1似乎经常受累。本综述提供了导致CeH的不同遗传缺陷的最新说明。